Application to Drug Substance Crystallization Marino Nebuloni
|
|
- Lesley Hood
- 6 years ago
- Views:
Transcription
1 Application to Drug Substance Crystallization Marino Nebuloni REDOX Monza Parma University
2 Objectives of the presentation 1.Crystallization principles 2.What are QbD (Quality by Designe) and PAT (Process Analytical Technique)? 3.Analytical Techniques for PAT Application 4.Examples of PAT in Crystallization of API 5.Summary
3 Crystallization Processes 1 Crystallization is a core technology of many sectors in the chemical process and allied industries 2 Involves a variety of business sectors, e.g..agrochemicals, catalysts, dyes/pigments, electronics, food/confectionery, health products, nano-materials, nuclear fuel, personal products & pharmaceuticals 3 Processes can involve complex process chemistry together with non-ideal reactor hydrodynamics.hence can be difficult to understand and scale-up from laboratory to production scale operation 4 Crystallization also forms part of a wider process system
4 Crystallization Process Systems
5 CRYSTAL CHARACTERISTICS
6 Phase Equilibria Understanding phase equilibria is crucial to crystallizer operation Solubility-supersolubility diagram
7 Supersaturation Supersaturation, c, is sometimes called the concentration driving force
8 Crystallization Kinetics particle formation processes depend upon supersaturation
9 Process Analytical Technology (PAT) in the assessment and control the Critical Variables in Crystallization Processes
10 The application of PAT to the crystallization means understand IDENTIFICATION MEASUREMENT PAT PREDICTION
11 Scientific Contributions for the application of the PAT Analytical Sensor Quality and Hazard design PAT Process Control Data Data Analysis Analysis
12 Fundamental Approach in Development Traditional Approach Causal Links Predict Performance Quality by Design Scale Up Prediction Real Time Control for Continuous Improvement Decision Based On Univariate Approach Data Derived From Trial & Error Experimentation Modeling for Mechanistic Understanding DOE (Multivariate Systems Approach) Identification of PCCP* PAT PCCP* Process Critical Control Parameter
13
14 Impact of On-line Process Analyzers - Crystallization - PAT Raw Material Reaction Purification Crystallization Isolation & Drying API Quality/Productivity Mechanistic & kinetic knowledge Parametric boundary Access to extreme conditions Real time monitoring & control Continuous quality assurance
15 Application for On-line Process Monitoring - Crystallization - SOLID STATE Physical properties intrinsic external Reaction Calorimetry FT-IR/ATR spectroscopy Raman Spectroscopy FBRM -Focuse BeamReflectance Measurements
16 Instrument characteristic requirements for on-line process monitoring
17 Analytical Techniques available on Spectroscopic Techniques the market NIR FT-IR/ATR Raman Light Scattering (laser) Mass-Spectrometry X-ray (Diffraction & Fluorescence) Turbidimetric and Rifractometric Techniques Turbidimetry Densitometry rifractometry Particles physical and morphologic properties Particle Size (FBRM) Photoacustic Etc.
18 Measurement technology review
19 REVIEW
20 Polymorphism and Particle Size modification during a crystallization process controlled by RC1, FT- IR/ATR and FBRM During a crystallization process of an API was observed : at the first step after seeding : * crystals with large Particle Size and polymorphic Form I at the second step (cooling phase): * Increase of small crystals instead of growth and transformation of the solid into polymorphic Form II
21
22 First Step : Lab Scale FT-IR/ATR & FBRM (Lasentec) into RC1 calorimeter FT-- IR/ATR FBRM RC1
23 Crystallization Heat of API recorded by RC1 seeding ---- Form I Form I I --- Heat developed on the crystallization Reactor Temperature Conversion Heat Flow time (min)
24 N Totale N Conteggi di Particelle Esempio I Valore medio Crystallization Mean Diameter Profile and and Particles distribution count of byparticles FBRM Mean diameter DIAMETRO MEDIO Seeds Seeds (1) (1) (2) (2) (3) (3) Tr=36-->19 C Time (min) (4) (4) N Particles Maximum Growth Rate Time (min) 50 um 250 um Tr=36-->19 C (5) (5) Diametro Diametro Medio Medio (um) (um)
25 Esempio I FT-IR Polymorphic Form modification during the crystallization controlled by FT-IR/ATR (2) N Particles 0.45 N Totale di Particelle Form I (initial) (1) (3) (4) Tr=36-->19 C Form II (Final) Concentrazione Relativa Seeds (5) Time (min) -0.05
26 Second Step: lab-max & mini plant
27 Reaction Calorimetry RC1 profiles Heat developed on the crystallization Reactor Temperature With only one solvent (standard process) 3 Conversion 2 1 Heat Flow time (min) Seeds addition Crystallization induced by the cosolvent Modify method (with co-solvent) Heat flow Conversion time (min) -0.2
28 Third Step: production scale
29 On-line Control of crystallization of polymorphic forms and Particle Size by FBRM (Lasentec) Active Principle (API) can exist into two polymorphic forms Form I - m.p = 222 C By slow cooling Form II - m.p = 219 C By rapid cooling
30 FBRM (Focused Beam Reflectance Measurement) Probe scheme nicr CSDIR c1ir TuIR c2ir TICR TICR Batch Cooling Crystallizer: Experimental Set-Up c1ir: Concentration Measurement 1 (Oscillating U-Tube Measurement) c2ir: Concentration Measurement 2 (Ultrasound Velocity Measurement) TuIR: Turbidometer (Backscatter Measurement) CSDIR: Crystal size Distribution Measurement (Chord Length Measurement FBRM) jacketed crystallizer
31 Particle Size distribution by FBRM during the cooling steps Cooling step from 90 to 55 C Particle Size distribution on the time at 55 C
32 Final Particle Size distribution in relation to the process temperature
33 FBRM application for monitoring an API crystallization process influenced by ph, concentration, Temperature and Induction time
34 Critical Quality Paramiters Concentration ph Solid state FBRM on line Filtrability Induction Time
35 Information collected on the time during the crystallization
36 Time 0 time Nucleation Growing Induction Time
37 Laboratory Scale-up Production F.B.R.M. F.B.R.M. Definition of CQa Quality Control P.A.T. Optimization
38 Experimental Data N particelle Particelle 1-3 um Particelle 3-5 um Particelle 5-10 um Particelle um Particelle um Particelle um N totale di particelle Inizio 2h Tempo (h)
39 ph= 6.7 concentration : A mg/ml Poor filtrability Design Of Experiment Filtrazione F 7 A F 7 B F 6.7 A F 6.7 B NO F 7 A ph NO F 7 B NO F 6.7 A NO F 6.7 B Concentrazione
40 um 3-5 um 5-10 um um um um N totale particelle N particelle N particelle totali Inizio 3h tempo (h)
41 Final Result Filtrability F 7 A F 7 B 3 h F 6.7 A 2 h F 6.7 B NO F 7 A ph NO F 7 B 0.5 h NO F 6.7 A 0 h NO F 6.7 B Concentration Time
42 Impact of Agitation on Particle Size Distribution
43 Effect of Agitated Drying
44 Monitoring in Tumble Dryer
45 Continuous Crystallization controlled by PAT AIMS 1. To deliver consistent crystal quality (morphology, size and size distribution), not achieved consistently in large batch operations. 1. To investigate additional manufacturing advantages of COBC for crystallisation in continuous or semicontinuous modes 1. Improved filterability; 1. Reduced crystallisation time, space usage and utility and energy consumption; 1. Provision of seeding along the flow path.
46 Continuous Oscillatory Baffled Crystalliser Courteously by Jon-Paul Sherlock, AstraZeneca Continuous Material moves continuously through Oscillatory Although there is a net flow through the unit, the local flow moves back and forth Baffled. Reactor Small baffles are installed along the length to promote turbulence and hence mixing Or crystalliser, or extractor, or
47 How is mixing achieved? Mixing Mechanism Mixing controlled by oscillation Plug flow at relatively low flows Each cell is a CTSR Handles particulates
48 material moves through the crystalliser
49 Well controlled cooling rate
50 Product performance
51 Summary Advantage of PAT application i) Understanding of the uncertainties of the process; ii) Identification and quantification of the failure mechanisms on the crystallization process iii) Estimation of the risks associated with each step of the process. iv) Documentation of physical characteristics for the Regulatory Requirements
52 Thank you for your attention! Marino Nebuloni Parma University
Quality by Design nella cristallizzazione degli API
Quality by Design nella cristallizzazione degli API (QbD in API crystallization process) Marino Nebuloni (REDOX srl Monza) Content Recent ICH and FDA Guidelines ICH Q8, Q9 and Q10 Quality by Design (QbD)
More informationPat Monitoring of Particles in API Manufacture and Formulation
Pat Monitoring of Particles in API Manufacture and Formulation By: Brian O Sullivan Ph.D PAT Seminar Singapore Sept 11 th 2007 brian.osullivan@mt.com What do these have in common? Space shuttle Lipitor
More informationDr Thomas McGlone. Optimisation of Industrial Crystallisation Processes: Case Studies from the CMAC Future Manufacturing Research Hub
Dr Thomas McGlone CMAC Technical Operations Manager Optimisation of Industrial Crystallisation Processes: Case Studies from the CMAC Future Manufacturing Research Hub Synopsis Brief overview of the CMAC
More informationStrategic Implantation of PAT : FDA Perspective
Strategic Implantation of PAT : FDA Perspective Moheb M. Nasr, Ph.D. CDER, FDA MOHEB.NASR@FDA.HHS.GOV IFPAC 2008 Strategic Implantation of PAT Baltimore, MD January 27, 2008 Outline The Desired State -
More informationNucleation & Growth Kinetics: A Comparison of FBRM and Laser Diffraction
Nucleation & Growth Kinetics: A Comparison of FBRM and Laser Diffraction Paul Barrett & Brian Glennon (paul.barrett@ucd.ie & brian.glennon@ucd.ie) Department of Chemical Engineering, University College
More information냉각결정화기술의응용전략 -2 고려대화공생명공학과양대륙
냉각결정화기술의응용전략 -2 고려대화공생명공학과양대륙 결정화공정의모델링 2 결정화모델의구성및활용 Seed properties: Size, shape, Operating conditions Nucleation and crystal growth kinetic parameters Measured final crystal size distribution Population
More informationContinuous Crystallization of Pharmaceuticals. Allan S. Myerson
Continuous Crystallization of Pharmaceuticals Allan S. Myerson Dept. of Chemical Engineering Novartis-MIT Center for Continuous Manufacturing Massachusetts Institute of Technology Crystallization Process
More informationInsight into solid state properties during processing
Insight into solid state properties during processing Jukka Rantanen jtr@farma.ku.dk Outline * Background role of process analysis * Solid state analysis, special emphasis on interfacing and data analysis
More informationWhite Paper. Crystallization in Process Chemistry Applying Simple PAT Tools. Author: Des O'Grady PhD, METTLER TOLEDO
Crystallization in Process Chemistry Applying Simple PAT Tools Author: Des O'Grady PhD, Crystallization is a common step used during the synthesis of organic compounds to isolate and purify the desired
More informationDeveloping Pharmaceutical Continuous Crystallization Processes - Knowledge & Gaps. Chris Price on behalf of the IMI team Product Development
Developing Pharmaceutical Continuous Crystallization Processes - Knowledge & Gaps Chris Price on behalf of the IMI team Product Development Context - Innovative Manufacturing Initiative Move from Batch,
More informationDr Claire MacDonald Business Development Manager CMAC National Facility
Dr Claire MacDonald Business Development Manager CMAC National Facility This presentation will cover CMAC Overall Vision CMAC National Facility Capabilities and Expertise API Process Development Secondary
More informationAgilent TRS100 Raman. Quantitative Pharmaceutical Analysis System
Agilent TRS100 Raman Quantitative Pharmaceutical Analysis System Agilent TRS100 Raman Streamlined Quality Control Fast Test hundreds of intact tablets or capsules in minutes Simple Quantify active pharmaceutical
More informationProcess Analytical Technology Applications in Crystallisation Development
Process Analytical Technology Applications in Crystallisation Development Amy Gillon-Robertson Process Engineering, Process R&D, AstraZeneca R&D Charnwood, Loughborough, UK Overview Process Analytical
More informationLoughborough University Institutional Repository. This item was submitted to Loughborough University's Institutional Repository by the/an author.
Loughborough University Institutional Repository Application of process analytical technology (PAT) tools for the better understanding and control of the crystallization of polymorphic and impure systems
More informationRegulatory Assessment
Implementation of ICH Q8, Q9, Q10 Regulatory Assessment International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Presentation Overview Goal
More informationControlled Crystallization of Salts from Nuclear Waste Solutions 15235
Controlled Crystallization of Salts from Nuclear Waste Solutions 15235 Daniel Griffin*, Martha A. Grover*, Yoshiaki Kawajiri*, Ronald W. Rousseau* * Georgia Institute of Technology ABSTRACT Crystallization
More informationSolubility Curve and Metastable zone Width using Lasentec FBRM & PVM
Solubility Curve and Metastable zone Width using Lasentec FBRM & PVM Lasentec Users Forum, Charleston, 2002 Paul Barrett, Brian Glennon & Brian O Sullivan (paul.barrett@ucd.ie, brian.glennon@ucd.ie, brian.osullivan@ucd.ie)
More informationCMAC: A National Research Centre in Continuous Manufacturing and Crystallisation
CMAC: A National Research Centre in Continuous Manufacturing and Crystallisation Prof Alastair J. Florence, EIPG Scientific Symposium, Technology Advances Impacting Pharmaceutical Industry, 17 April 2016
More informationContinuous Crystallisation and Manufacture
Continuous Crystallisation and Manufacture Professor Xiong-Wei Ni, BSc, PhD, CEng, CSci, FIChemE, FRSC Founder and Technical Director Email: x.ni@nitechsolutions.co.uk www.nitechsolutions.co.uk 10 Cammo
More informationICH Q8/Q8(R)
Pharmaceutical Quality for the 21 st Century Temple University May 06, 2008 Joseph Famulare, Deputy Director FDA CDER Office of Compliance CDER Office of Compliance and the Critical Path Initiative Since
More informationBatch Statistical Process Control (BSPC): a powerful multi-level risk & process analytics tool
Batch Statistical Process Control (BSPC): a powerful multi-level risk & process analytics tool AgroStat 2016 March 21-24, 2016 Lausanne Sébastien Preys Ondalys France Consulting and Training in Chemometrics
More informationSiemens AG All rights reserved.
How to create a PAT data management platform to support Continuous Production 8th Annual PAT and QbD Conference, London, February 16 th, 2011 Jan Verelst Back in time Page 2 What caused this disaster?
More informationPQLI Engineering Controls and Automation Strategy
J Pharm Innov (2008) 3:88 94 DOI 10.1007/s12247-008-9031-5 PRODUCT QUALITY LIFECYCLE IMPLEMENTATION (PQLI) INNOVATIONS PQLI Engineering Controls and Automation Strategy Ray Bolton Stephen Tyler Published
More informationABOUT LOUGHBOROUGH UNIVERSITY CHEMICAL ENGINEERING RESEARCH ASSOCIATE CONTINUOUS CRYSTALLISATION AND MANUFACTURING REQ15805 OCTOBER 2015
ABOUT LOUGHBOROUGH UNIVERSITY CHEMICAL ENGINEERING RESEARCH ASSOCIATE CONTINUOUS CRYSTALLISATION AND MANUFACTURING REQ15805 OCTOBER 2015 As part of the University s ongoing commitment to redeployment,
More informationPAT and Quality by Design exemplified in a Mock P2 submission for examplain tablets. Part 1: Concept and Principles Part 2: Mock P2 Submission
PAT and Quality by Design exemplified in a Mock P2 submission for examplain tablets Part 1: Concept and Principles Part 2: Mock P2 Submission 1 Part 1 Concept and Principles Introduction Rationale Concept
More informationTaking mechanistic models from R&D and Engineering into Operations
Taking mechanistic models from R&D and Engineering into Operations Andy Mitchell (Perceptive Engineering) Niall Mitchell (Process Systems Enterprise) Introductions 2 Process Systems Enterprise Who we are:
More informationContinuous Manufacturing
Continuous Manufacturing Continuous ing in the Industry Continuous processing has been adopted by the majority of process industries for the manufacturing of fluids (i.e. liquids and gasses) and solids
More informationPolymorph Screening Technology by Controlling Crystallization
A publication of 2221 CHEMICAL ENGINEERING TRANSACTIONS VOL. 32, 213 Chief Editors: Sauro Pierucci, Jiří J. Klemeš Copyright 213, AIDIC Servizi S.r.l., ISBN 978-88-9568-23-5; ISSN 1974-9791 The Italian
More informationScientific Considerations for Continuous API Manufacturing
Scientific Considerations for Continuous API Manufacturing Thomas O Connor, Ph.D. Office of Pharmaceutical Quality/Office of Testing and Research US FDA Center for Drug Evaluation and Research FDA PQRI
More informationPolymorph Screening Strategies and a Concomitant Polymorph Case Study
Polymorph Screening Strategies and a Concomitant Polymorph Case Study Aniruddh Andy Singh, Ph.D. Mahmoud Mirmehrabi, Ph.D., P.Eng. Johnson Matthey Pharma Services Chemical and Crystallization Research
More informationApplication of Quality by Design (QbD) in product development. James E. Polli September 16, 2015
Application of Quality by Design (QbD) in product development James E. Polli jpolli@rx.umaryland.edu September 16, 2015 Pharmaceutical Equivalence Same active ingredient(s) Same dosage form Same route
More informationMaximizing efficiency: Process Analytical Technologies and Process Intensification
Maximizing efficiency: Process Analytical Technologies and Process Intensification Alejandro Rosales Sci & and Tech Mng in Innovació i Recerca Industrial i Sostenible, S.L. (IRIS) Innovation Manager in
More informationPLEASE SCROLL DOWN FOR ARTICLE
This article was downloaded by: [Wyeth Research] On: 29 April 2009 Access details: Access Details: [subscription number 904910528] Publisher Informa Healthcare Informa Ltd Registered in England and Wales
More informationWater in Food, Lausanne 2004
Water in Food, Lausanne 2004 Characterising the Amorphous State in a Pharmaceutical Powder Using Moisture and Organic Vapour Sorption Frank Thielmann,* Daniel Burnett,** Jürgen Adolphs,*** *Surface Measurement
More informationSmall Molecule Crystallization
Small Molecule Crystallization Jessica K. Liang Department of Chemical Engineering Illinois Institute of Technology ACS Summer School July 2003 Chicago IL Overview Ø Basic Crystal Science Ø Crystallization
More informationInline Monitoring to Improve Purification of Biological Systems
Inline Monitoring to Improve Purification of Biological Systems Jack Shu Technology and Application Consultant Outline Bioprocess Workflow Inline Particle Characterization Tools Applications - Flocculation
More informationProcess analytical technology based approaches for the monitoring and control of size and polymorphic form in pharmaceutical crystallisation processes
Loughborough University Institutional Repository Process analytical technology based approaches for the monitoring and control of size and polymorphic form in pharmaceutical crystallisation processes This
More informationPQLI Control Strategy Model and Concepts
J Pharm Innov (008) :95 104 DOI 10.1007/s147-008-905-1 PRODUCT QUALITY LIFECYCLE IMPLEMENTATION (PQLI) INNOVATIONS PQLI Control Strategy Model and Concepts Bruce Davis Line Lundsberg Graham Cook Published
More informationApplication Note. Introduction. Analysis of crystal polymorphism by Raman Spectroscopy for Medicine Development
Application Note Analysis of crystal polymorphism by Raman Spectroscopy for Medicine Introduction Crystal polymorphism is a phenomenon where Raman applications in the pharmaceutical Industry compounds
More informationCHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE
CHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE Paul Stott, PhD Head of US Product Development AstraZeneca ICH Quality Guidelines Workshop BioKorea 2007 Sept 13-14
More informationCrystal Growth from Melts
Crystal Growth from Melts Applications to Growth of Groups 1 and 2 Crystals Bimalendu Narayan Roy Sheffield City Polytechnic, UK JOHN WILEY & SONS Chichester New York Brisbane Toronto Singapore Contents
More informationWhite Paper. Advanced Strategies to Control Crystal Size Distribution. Author: Des O Grady PhD, METTLER TOLEDO
Advanced Strategies to Control Crystal Size Distribution Author: Des O Grady PhD, Many products in the pharmaceutical and high value chemical industries go through multiple crystallization steps during
More informationAmorphous Quantitation Strategy for Crystalline Drug Substance a GSK Perspective. Peter Varlashkin GSK, Durham, NC, USA PPXRD 11
Amorphous Quantitation Strategy for Crystalline Drug Substance a GSK Perspective Peter Varlashkin GSK, Durham, NC, USA PPXRD 11 This document was presented at PPXRD - Pharmaceutical Powder X-ray Diffraction
More informationA Study on Crystallization of Oxalic Acid in Batch Cooling Crystallizer
C. SRINIVASAKANNAN et al., A Study on Crystallization of Oxalic Acid, Chem. Biochem. Eng. Q. 16 (3) 125 129 (2002) 125 A Study on Crystallization of Oxalic Acid in Batch Cooling Crystallizer C. Srinivasakannan*,
More informationQuality by Design Considerations for Analytical Procedures and Process Control
Quality by Design Considerations for Analytical Procedures and Process Control Moheb M. Nasr, Ph.D. ONDQA/CDER/FDA IFPAC 2009 Baltimore, MD January 26, 2009 1 Outline Background on FDA Initiatives and
More informationOn-line Monitoring of the Spherical Crystallization of Salicylic Acid. Omar S. Hasan 1 Helen M. Buettner 1 San Kiang 2
On-line Monitoring of the Spherical Crystallization of Salicylic Acid Omar S. Hasan 1 Helen M. Buettner 1 San Kiang 2 1 Department of Chemical and Biochemical Engineering Rutgers, The State University
More informationApplication Note. Raman Spectroscopy Analysis of Crystalline Polymorphs for Pharmaceutical Development
Raman Applications in the Pharmaceutical Industry Impurity Analysis (Identification of micro impurities - sizes less than 1 µm) Evaluation of Synthetized Compounds (Structural analysis in combination with
More informationNIRS, PAT, RTR testing EU experience and regulatory perspective
NIRS, PAT, RTR testing EU experience and regulatory perspective Heidelberg, Germany October 2013 European Compliance Academy (ECA) Overview of the presentation General considerations Cases submitted in
More informationThe Move to 100% Testing of Incoming Raw Material. Ravi Kalyanaraman, Ph.D. Global Analytical Technology Bristol-Myers Squibb
The Move to 100% Testing of Incoming Raw Material Ravi Kalyanaraman, Ph.D. Global Analytical Technology Bristol-Myers Squibb Current Situation Current procedure in pharmaceutical industry is to obtain
More informationThe use of surrogates for dissolution testing for Immediate Release (IR) formulations, when is it feasible?
The use of surrogates for dissolution testing for Immediate Release (IR) formulations, when is it feasible? Limin Zhang (Bristol-Myers Squibb Company) Andre Hermans (Merck & Co., Inc.) 2017 M-CERSI Workshop
More informationVERISEQ NUCLEATION BETTER CONTROL OF NUCLEATION IN LYOPHILIZATION
VERISEQ NUCLEATION BETTER CONTROL OF NUCLEATION IN LYOPHILIZATION IMPORTANCE OF CONTROLLED NUCLEATION Lyophilization, or freeze drying, is an important downstream process for stabilizing pharmaceutical
More informationPhysical characterization and in vitro cytotoxicity screening of single-walled carbon nanotubes (SWNTs)
Physical characterization and in vitro cytotoxicity screening of single-walled carbon nanotubes (SWNTs) Ruhung Wang, Ph.D. (ruhung.wang@utdallas.edu) Bionano Science Group University of Texas at Dallas
More informationA.1 Physical and Chemical Properties of Model Systems
175 Appendix A.1 Physical and Chemical Properties of Model Systems Within this work the following substances were used: Ammonium chloride (Carl Roth GmbH + Co. KG, > 99.5% Ph. Eur., USP, BP) Ascorbic acid
More informationDevelopment of Continuous Crystallisation Processes for Consistent Crystal Products
Development of Continuous Crystallisation Processes for Consistent Crystal Products Alastair J. Florence, CMAC, University of Strathclyde Drug Delivery and Formulation Forum, Berlin May 2016 Drivers for
More informationPHEN 612 SPRING 2008 WEEK 13 LAURENT SIMON
PHEN 612 SPRING 2008 WEEK 13 LAURENT SIMON Crystallization Crystallization is a common separation process in Commodity inorganic industry (e.g., salts) Food industry (e.g., sugars) Pharmaceutical manufacturing
More informationHow the European Pharmacopoeia Provides the Framework to Implement QbD Principles
How the European Pharmacopoeia Provides the Framework to Implement QbD Principles Dr Emmanuelle Charton Deputy Head, European Pharmacopoeia Department, EDQM, Council of Europe Structure of the Presentation
More informationApplying QbD to Bioprocesses
Applying QbD to Bioprocesses IFPAC Cortona Conference on, QbD/PAT: Advanced Technological and Regulatory Developments Impacting Pharmaceutical Manufacturing and Control, 19 th -22 nd September 2010 Definitions
More informationContinuous Manufacture: Real-time Multivariate process monitoring
Continuous Manufacture: Real-time Multivariate process monitoring Melanie Dumarey, Peter Hamilton, Christian Airiau GlaxoSmithKline, 9SEP15 Introduction GSK is investing in Continuous Manufacture for drug
More informationTHE EFFECT OF MIXING ON THE METASTABLE ZONE WIDTH AND NUCLEATION KINETICS IN THE ANTI-SOLVENT CRYSTALLIZATION OF BENZOIC ACID
THE EFFECT OF MIXING ON THE METASTABLE ZONE WIDTH AND NUCLEATION KINETICS IN THE ANTI-SOLVENT CRYSTALLIZATION OF BENZOIC ACID D. O Grady, M. Barrett, E. Casey and B. Glennon School of Chemical and Biochemical
More informationCrystallization Methods and Protein Crystal Properties. (adapted from )
Crystallization Methods and Protein Crystal Properties (adapted from http://www.bioc.rice.edu/~bios482/xtal_ppt/ ) Four major steps in crystallization Obtain large amounts of pure protein samples Choose
More informationThermo Scientific ARL EQUINOX 100. X-ray Diffractometers
Thermo Scientific ARL EQUINOX 100 X-ray Diffractometers High performance in a compact size Thermo Scientific ARL EQUINOX 100 X-ray diffractometer (XRD) is designed to meet structural and phase analysis
More informationIdentification of CPPs based on CQAs & Mechanistic Process & Product Understanding: A Case Study
Identification of CPPs based on CQAs & Mechanistic Process & Product Understanding: A Case Study Ajit S. Narang, Ph.D. Bristol-Myers Squibb, Co. 2 nd FDA/PQRI Conference on Advancing Product Quality Bethesda,
More informationApproval Application Form for Sakura Bloom Tablets
Approval Application Form for Sakura Bloom Tablets Mock-up for Columns of Manufacturing Methods and Specifications & Test Methods for Drug Products (sample description) Study project for regulatory harmonization
More informationPAT - Seen from an Automation and Information Solutions Provider
PAT - Seen from an Automation and Information Solutions Provider Alberto Rossi Rockwell Automation 09. October 2007 Copyright 2007 Rockwell Automation, Inc. All rights reserved. 1 Agenda 1. 1. Rockwell
More informationSpectroscopy Fiber Optic Probes for In-line Analytical Analysis
Spectroscopy Fiber Optic Probes for In-line Analytical Analysis FlexiSpec product line is a cluster of innovative Fiber Optic Probes and Fiber Probe Couplers designed for in-line analytical analysis in
More informationValidation of Pharmaceutical Manufacturing Process Focus: APIs.
Validation of Pharmaceutical Manufacturing Process Focus: APIs Validations: Regulatory History (US FDA) Sterilisation 1977 Aseptic processing 1979 Water Systems 1981 Non-sterile Mfg Process 1987 Revised
More informationInvestigating Differences in Solubility Between Crystalline and Amorphous Forms of Pharmaceuticals
Investigating Differences in Solubility Between Crystalline and Amorphous Forms of Pharmaceuticals Rhea Brent Pharmaceutical Analytical Research and Development AstraZeneca Alderley Park Aim To determine
More informationMitigating Commercial Risks in Continuous Manufacturing Drug Product
Mitigating Commercial Risks in Continuous Manufacturing Drug Product Ian Leavesley Eli Lilly Indianapolis, Indiana Commercializing Continuous Processing in Pharma Boston, MA Jan 30 th Feb 1 st 2017 Outline
More informationStudying Amorphous Pharmaceutical Materials by Powder X-Ray Diffraction and other Solid-State Techniques
Studying Amorphous Pharmaceutical Materials by Powder X-Ray Diffraction and other Solid-State Techniques Shawn Yin, George Crull, Martha Davidovich, Denette Murphy, Anisha Patel, Beth Sarsfield, Ray Scaringe,
More informationQbD (Quality by Design) Has industry benefited from this? WHITE PAPER.
WHITE PAPER www.makrocare.com/consulting There are many facets to engineering for a healthier world. It is important to understand what surrounds us today and look into what we believe will surround us
More informationOptical microscopy Theoretical background Galina Kubyshkina
Optical microscopy Theoretical background Galina Kubyshkina Elektromaterial Lendava d.d., Slovenia Crystalline materials presence of a unit (cell), which is periodically repeated in space regular structure
More informationLessons Learned in Tech Transferring a QbD/PAT enabled process
Lessons Learned in Tech Transferring a QbD/PAT enabled process 1 Martin Warman, Analytical Development Joseph Medendorp, Technical Operations 26 th September 2012 Possible uses for PAT Identifying critical
More informationNeeds and Opportunities for Continuous Manufacturing (industrial perspective)
Technical R&D/CHAD/ CM Unit Needs and Opportunities for Continuous Manufacturing (industrial perspective) Markus Krumme, Unit Head CM Cambridge September 27, 2016 Every morning, I have a dream: Of a world,
More informationCharacterization of Li 3+ /Mg SO 4.7H 2 O Crystal
Hinthada University Research Journal 2016, Vol. 7, No. 1 26 Characterization of Li 3+ /Mg SO 4.7H 2 O Crystal May Thwe Soe 1, Win Kyaw 2, Than Tun 3 Abstract Crystals of Li 3+ (1 mol%) doped Magnesium
More informationRegulatory Consideration for the Characterization of HOS in Biotechnology Products
Regulatory Consideration for the Characterization of HOS in Biotechnology Products Maria Teresa Gutierrez Lugo, Ph.D. OBP/CDER/FDA 5 th International Symposium on Higher Order Structure of Protein Therapeutics
More informationPreliminary Studies on In Situ Monitoring of Lactose Crystallization Using Focused Beam Reflectance Measurement
Dairy Research 214 Preliminary Studies on In Situ Monitoring of Lactose Crystallization Using Focused Beam Reflectance Measurement K. Pandalaneni, J.K. Amamcharla Summary Isothermal crystallization of
More informationCOPYRIGHTED MATERIAL. Introduction to Crystallization Issues. Chapter 1
Chapter 1 Introduction to Crystallization Issues Crystallization has been the most important separation and purification process in the pharmaceutical industry throughout its history. Many parallels exist
More informationImplementation of a Multi-product Process Intensified Plant
Implementation of a Multi-product Process Intensified Plant Exploring Continuous Processing YCF Seminar: AstraZeneca, Macclesfield April 24, 2013 Nigel A Fletcher Manager, Speciality Products Foster Wheeler
More informationVERISEQ nucleation. Improved lyophilisation through controlled nucleation.
VERISEQ nucleation. Improved lyophilisation through controlled nucleation. 02 Importance of controlled nucleation. Improving results with VERISEQ nucleation Lyophilisation, or freeze drying, is an important
More informationManufacturing Considerations for Liposomal Drug Products. Nanotechnology Workshop January 2014
Manufacturing Considerations for Liposomal Drug Products Nanotechnology Workshop January 2014 Applications of Nano-Scale Drug Delivery Systems Wide range of carrier types Liposomes Solid core nanoparticles
More informationCOMPARISON OF SEMICONTINUOUS AND BATCH PRECIPITATION OF CALCIUM CARBONATE
COMPARISON OF SEMICONTINUOUS AND BATCH PRECIPITATION OF CALCIUM CARBONATE Dr. Sc. D. Kralj, Dipl.-Ing. M. Ukrainczyk, Dr. Sc. J. Kontrec, Dr. Sc. V. Babić-Ivančić, Dr. Sc. Lj. Brečević Laboratory for Precipitation
More informationPAT for the On-line Characterization of Continuous Manufacturing Systems
PAT for the On-line Characterization of Continuous Manufacturing Systems Thomas O Connor, Ph.D. Office of Pharmaceutical Science FDA/PQRI Conference: Innovation in Manufacturing and Regulatory Assessment
More informationParticle Size Method Development and Validation in Support of NanoCrystal Colloidal Dispersion Formulation Characterization
Particle Size Method Development and Validation in Support of NanoCrystal Colloidal Dispersion Formulation Characterization Webinar Sponsored By: August 2010 Joost Strasters Overview Background: NanoCrystal
More informationBatch Reactor Temperature Control Improvement
Batch Reactor Temperature Control Improvement Flávio P. Briguente (Monsanto) and Greg McMillan (CDI Process & Industrial) Key words: batch reactor, temperature control, solubility curve. ABSTRACT Temperature
More informationSelective Crystallization of Metastable α-form of L- glutamic Acid through Feedback Concentration Control. Introduction
Selective Crystallization of Metastable α-form of L- glutamic Acid through Feedback Concentration Control Nicholas C. S. Kee,,, Reginald B. H. Tan, and Richard D. Braatz University of Illinois at Urbana-Champaign,
More informationNew generation of industrial crystallizers. Numerical simulation of a bubble growth induced by laser MOHAMMAD GHEISI
New generation of industrial crystallizers Numerical simulation of a bubble growth induced by laser MOHAMMAD GHEISI Department of Applied Mechanics CHALMERS UNIVERSITY OF TECHNOLOGY Gothenburg, Sweden
More informationPAT Initiative Pilot Project API Production. Gerhard Korb. Sanofi-Aventis Deutschland GmbH. Process Development Chemistry
Gerhard Korb Sanofi-Aventis Deutschland GmbH Process Development Chemistry Chemical & Particle Engineering Frankfurt Summary PAT Initiative Pilot Project API Production Tools - Definition Example Additional
More informationThe Raman effect, discovered in 1928 by C.V. Raman in his
Refined Raman Spectroscopy Bringing New Insight into INDUSTRIAL PROCESSES Sophie Morel and Fran Adar Fiber probes and ease of use make Raman spectroscopy systems attractive for monitoring process control
More informationPharmaceutical Manufacturing Technology Centre
Pharmaceutical Manufacturing Technology Centre Research themes for Initial Research Programme Call for Proposals The Centre will focus on advanced pharmaceutical manufacturing technologies with an initial
More information3. STATE OF ART AND OBJECTIVES OF THESIS
3. STATE OF ART AND OBJECTIVES OF THESIS 3.1. State of art 3.1.1. Crystallization time of drops From the simple model for droplet solidification [WAT92], the normalized crystallization time can be calculated
More informationHow to Identify Critical Quality Attributes and Critical Process Parameters
How to Identify Critical Quality Attributes and Critical Process Parameters Jennifer Maguire, Ph.D. Daniel Peng, Ph.D. Office of Process and Facility (OPF) OPQ/CDER/FDA FDA/PQRI 2 nd Conference North Bethesda,
More informationLiquiSonic. SensoTech. Biotech applications. Protein and agent crystallization. Fermentor and filter control
LiquiSonic Biotech applications Protein and agent crystallization Fermentor and filter control Alcohol, solvent, nutrient, bio mass concentrations Phase interface detection GmbH, Steinfeldstraße 3, D-39179
More informationThermo Scientific ARL EQUINOX X-ray Diffractometers
Thermo Scientific ARL EQUINOX 1000 X-ray Diffractometers High performance in a compact size Thermo Scientific ARL EQUINOX 1000 X-ray diffractometer (XRD) is designed to meet structural and phase analysis
More informationChapter 4: Recrystallization & Melting Point
Chapter 4: Recrystallization & Melting Point Recrystallization A purification technique for impure solid compounds A several-step process Can be on on a microscale or macroscale Melting Point Verifies
More informationAchieving Quality Beyond Compliance Through Continuous Manufacturing
Achieving Quality Beyond Compliance Through Continuous Manufacturing, Ph.D. Regional Head Quality Operation Novartis Pharma Disclaimer This presentation is based on publicly available information. These
More informationMOISTURE CONTENT MEASUREMENT CASE STUDY
MOISTURE CONTENT MEASUREMENT CASE STUDY This case study is based on a large research-focused health care company with a long tradition in pharmaceutical production and diagnostics. The company was founded
More informationOVERVIEW OVERVIEW. At Particle Sciences, We Deliver, taking your API from concept to clinic. Contact us at to see how we can help.
OVERVIEW OVERVIEW The majority of drug products being developed today face one or more technical challenges. Whether dealing with a new chemical entity or reformulating an existing active pharmaceutical
More informationIntegrating OSIsoft PI System with syntq for High Performance, Low Maintenance PAT Method Integration
Integrating OSIsoft PI System with syntq for High Performance, Low Maintenance PAT Method Integration Presented by: Mairtin Martin Mc Gadsby Namara (J&J) Martin Gadsby (Optimal) 1 Overview Introduction
More informationScientific and Regulatory Considerations for Implementing Mathematical Models in the Quality by Design (QbD) Framework
Online Exclusive from PHARMACEUTICAL ENGINEERING THE OFFICIAL TECHNICAL MAGAZINE OF ISPE NOVEMBER/DECEMBER 2014, VOL 34, NO 6 Copyright ISPE 2014 www.pharmaceuticalengineering.org regulatory compliance
More informationRole of QOS in PMDA Review Process
Role of QS in PMDA Review Process Junichi Fukuchi, Ph.D. ffice of Cellular and Tissue-based Products Pharmaceuticals and Medical Devices Agency (PMDA) Product Quality on Sep 17, 2014 1 Take-home massage
More information